How deforestation affects alcohol and tobacco use in Indonesia
Spatiotemporal effects and associations between deforestation and alcohol and tobacco use in Indonesia
['FUNDING_OTHER'] · WEILL MEDICAL COLL OF CORNELL UNIV · NIH-11458627
This project looks at whether forest loss in Indonesia is linked to changes in people's tobacco and alcohol use across different places and years.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEILL MEDICAL COLL OF CORNELL UNIV (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11458627 on ClinicalTrials.gov |
What this research studies
The team will combine satellite images that map forest loss with ten years (2012–2022) of nationally representative surveys about smoking and drinking. They will distinguish types of deforestation, such as wildfire versus logging, and compare timing and location of forest change to local patterns of substance use. Researchers will apply advanced environmental epidemiology and causal methods and create reproducible software to share their approaches. The goal is to explain community-level patterns and inform both environmental and public health responses.
Who could benefit from this research
Good fit: Ideal candidates are people who live in Indonesian communities affected by deforestation or who were included in the national cross-sectional surveys from 2012 to 2022.
Not a fit: People outside Indonesia or those seeking immediate clinical treatment for addiction are unlikely to receive direct personal benefit from this population-level research.
Why it matters
Potential benefit: If a link is found, the results could help policymakers and health programs target prevention and support in communities affected by forest loss to reduce increases in smoking and drinking.
How similar studies have performed: Previous work has tied large environmental disruptions to substance use, but combining satellite-based deforestation measures with decade-long national survey data is relatively novel.
Where this research is happening
NEW YORK, UNITED STATES
- WEILL MEDICAL COLL OF CORNELL UNIV — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CERNA-TUROFF, ILAN — WEILL MEDICAL COLL OF CORNELL UNIV
- Study coordinator: CERNA-TUROFF, ILAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.